101 Results for "

MBP protein

" in MedChemExpress (MCE) Product Catalog:
Products (101)

101 Results for "MBP protein" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-101525
CAS No.: 188343-77-3
Purity:  99.87%
Target:  

Parasite

Research Areas:  

Infection

MBP146-78 is a potent and selective inhibitor of cGMP dependent protein kinases.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-144088
CAS No.: 2380300-79-6
Purity:  98.86%
Synonyms: HPK1-IN-22
Target:  

MAP4K

Research Areas:  

Inflammation/Immunology Cancer

ZYF0033 is an orally active inhibitor of the hematopoietic progenitor cell kinase HPK1 with an IC50 of less than 10 nM based on the phosphorylation inhibition of MBP protein. ZYF0033 promotes anti-cancer immune responses and reduces phosphorylation of SLP76 (serine 376). ZYF0033 inhibits tumor growth in the 4T-1 syngeneic mouse model and leads to increased intratumoral infiltration of DCs, NK cells, and CD107a +CD8 + T cells, but not T cells, PD-1 +CD8 + T cells, TIM-3 +CD8 + Infiltration of T cells and LAG3 +CD8 + T cells was reduced .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100468
CAS No.: 1979192-13-6
Purity:  99.14%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research .
loading...
    loading...
Cat. No.: HY-112411
CAS No.: 216163-53-0
Purity:  98.35%
PD 174265 is a highly selective, reversible EGFR/ErbB2 tyrosine kinase inhibitor (IC50=0.45 nM) and cell differentiation inducer. By blocking receptor autophosphorylation and the downstream ERK signaling pathway (with an IC50 of 0.45 μM for full-length ERK), PD 174265 effectively inhibits tumor growth and exhibits antitumor activity without obvious toxicity in in vivo models. PD 174265 drives oligodendrocyte precursor cells to switch from a proliferative state to a differentiated state, significantly upregulates the expression of myelin proteins such as CNP, PLP and MBP, and induces neurite branching. PD 174265 shows no inhibitory effect on other kinases including insulin, PDGF and basic FGF receptors, and serves as a crucial tool molecule for investigating the treatment of human epidermoid carcinoma and the mechanism of myelin repair in multiple sclerosis .
loading...
    loading...
Cat. No.: HY-P10532
CAS No.: 121196-80-3
Target:  

PKC

Research Areas:  

Others Inflammation/Immunology

Myelin basic protein, MBP (68-86) is the portion of the 68th to 86th amino acid residues in the MBP protein sequence. Myelin basic protein, MBP (68-86) can act as an autoantigen, triggering the immune system to attack its own myelin. Myelin basic protein, MBP (68-86) is used as one of the immunogens in the experimental autoimmune encephalomyelitis (EAE) animal model to study immune responses associated with multiple sclerosis (MS) .
loading...
    loading...
Cat. No.: HY-P1048
CAS No.: 98474-59-0
Target:  

Peptides

Research Areas:  

Inflammation/Immunology

Myelin Basic Protein (MBP) (68-82), guinea pig is a fragment of myelin basic protein (MBP).
loading...
    loading...
Cat. No.: HY-P3073
CAS No.: 106128-98-7
Target:  

Peptides

Research Areas:  

Inflammation/Immunology

Myelin Basic Protein (1-11) is an encephalitogenic epitope of myelin basic protein (MBP). Myelin Basic Protein (1-11) can be used for induction of experimental autoimmune encephalomyelitis (EAE) .
loading...
    loading...
Cat. No.: HY-P3724
CAS No.: 604803-17-0
Target:  

Peptides

Research Areas:  

Inflammation/Immunology

MBP (146-170) is a myelin basic protein (MBP). MBP (146-170) can be used for the research of multiple sclerosis (MS) .
loading...
    loading...
Cat. No.: HY-P3940
CAS No.: 138250-62-1
Target:  

PKC

Research Areas:  

Others

Ac-MBP (4-14) Peptide is an acetylated MBP (4-14) peptide. MBP (4-14) Peptide is a very selective (protein kinase C) PKC substrate. Ac-MBP (4-14) Peptide can be used for PKC assay in extracts without prior purification to eliminate interfering protein kinases or phosphatases .
loading...
    loading...
Cat. No.: HY-P3739
CAS No.: 136132-68-8
Target:  

Peptides

Research Areas:  

Others

[pGlu4]-Myelin Basic Protein (4-14) is the phosphorylated 4-14 fragment (EKRPSQRSKYL) of myelin basic protein (MBP) . [pGlu4]-Myelin Basic Protein (4-14) surrounds the serine residue in position 8 of the myelin basic protein .
loading...
    loading...
Cat. No.: HY-P1996
CAS No.: 178823-49-9
Synonyms: NBI-5788
Target:  

Peptides

Tiplimotide (NBI-5788) is an altered peptide ligand (APL) designed from an immunodominant region (83-99) of the neuroantigen myelin basic protein (MBP). Tiplimotide can selectively reduce the production of inflammatory cytokines by pathogenic T-cells. Tiplimotide can be used for the research of multiple sclerosis (MS) .
loading...
    loading...
Cat. No.: HY-P10428
Target:  

HPV

Research Areas:  

Infection

E6AP-mimicking peptide (compound 13) is a high-affinity, selective, irreversible and potent peptide-based covalent HPV16 E6 inhibitor targeting the 16E6 oncoprotein using a cysteine-reactive acrylamide warhead. E6AP-mimicking peptide has a Ki of 17 nM. E6AP-mimicking peptide targets all residues appearing in the binding pocket of E6 to disrupt the binding interface of 16E6 and E6AP. E6AP-mimicking peptide selectively binds and crosslinks to MBP-16E6 in PBS or a protein mixture .
loading...
    loading...
Cat. No.: HY-P1734
CAS No.: 125366-42-9
Target:  

PKC

Research Areas:  

Neurological Disease

Ac-MBP 1-11, a short peptide sequence, is the major encephalitogenic epitope in myelin basic protein (MBP) .
loading...
    loading...
Cat. No.: HY-P1289
CAS No.: 99026-78-5
Target:  

PKC

Research Areas:  

Others

[Ala113]MBP(104-118) is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 28-62 μM .
loading...
    loading...
Cat. No.: HY-P1289A
CAS No.: 99026-77-4
Target:  

PKC

Research Areas:  

Others

[Ala107]MBP(104-118) is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 46-145 μM .
loading...
    loading...
Cat. No.: HY-P1289D
Target:  

PKC

Research Areas:  

Others

[Ala107]MBP(104-118) acetate is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 46-145 μM .
loading...
    loading...
Cat. No.: HY-P10522
CAS No.: 106128-97-6
Target:  

Peptides

Research Areas:  

Others

MBP Ac1-9 refers to a peptide fragment of myelin basic protein (MBP). MBP Ac1-9 is an immunodominant epitope in the experimental autoimmune encephalomyelitis (EAE) model, which can induce T cell immune response and lead to pathological changes similar to multiple sclerosis. MBP Ac1-9 can be used to study T cell activation and autoimmune response .
loading...
    loading...
Cat. No.: HY-P1289B
Target:  

PKC

Research Areas:  

Others

[Ala107]MBP(104-118) TFA is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 46-145 μM .
loading...
    loading...
Cat. No.: HY-P1289C
Target:  

PKC

Research Areas:  

Others

[Ala113]MBP(104-118) TFA is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 28-62 μM .
loading...
    loading...
Cat. No.: HY-P10525
CAS No.: 167278-49-1
Target:  

Peptides

Research Areas:  

Neurological Disease

MBP Ac1-9 (4Y) is a synthetic peptide derived from a fragment of myelin basic protein (MBP) that has undergone specific chemical modifications. MBP Ac1-9 (4Y) is able to form a complex with the MHC class II molecule I-Au and activate specific T cell receptor (TCR), thus playing a role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). MBP Ac1-9 (4Y) can be used to study autoimmune diseases, especially those involving the central nervous system, such as multiple sclerosis .
loading...
    loading...